Literature DB >> 6217893

Changes in the collagen of rat heart in copper-deficiency-induced cardiac hypertrophy.

R Dawson, G Milne, R B Williams.   

Abstract

Groups of rats were maintained from weaning on copper-supplemented or copper-deficient diets. After 2, 4, 6, 8 or 12 weeks animals were killed, their hearts were removed and the solubility and phenotype composition of the collagen of the hearts was studied. In the hearts from the copper-supplemented animals 35 to 45% of the collagen could be extracted after two treatments with pepsin but up to 74% could be extracted from the hypertrophied copper-deficient hearts. Almost all of the increase in the soluble material was found in the first pepsin extract. Electrophoretic analysis of the extracts showed that in the copper-supplemented hearts the ratio of Type III/Type I collagen increased about threefold between 2 and 6 weeks after weaning but by 8 weeks it had returned to about the level found at 2 weeks and was maintained at this level to the end of the experimental period. In the copper-deficient hearts the ratio of Type III/Type I collagen had increased about fivefold by 6 weeks after weaning and from 8 weeks to the end of the experimental period it remained at two to three times the value found in the copper-supplemented hearts. There was an indication that the relative proportion of Type V collagen was reduced in the copper-deficient hearts. The possible significance of these results in relation to the known pathological effects of copper deficiency on the cardiovascular system is discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6217893     DOI: 10.1093/cvr/16.10.559

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  13 in total

1.  Structural arrangement of the extracellular matrix network during myocardial development in the chick embryo heart.

Authors:  D Sanchez-Quintana; V Garcia-Martinez; D Macias; J M Hurle
Journal:  Anat Embryol (Berl)       Date:  1991

2.  Extracellular matrix arrangement in the papillary muscles of the adult rat heart. Alterations after doxorubicin administration and experimental hypertension.

Authors:  D Sanchez-Quintana; V Climent; V Garcia-Martinez; D Macias; J M Hurle
Journal:  Basic Res Cardiol       Date:  1994 Jul-Aug       Impact factor: 17.165

3.  Nutritional copper deficiency does not affect sponge granuloma formation in the rat.

Authors:  V Kishore; V Boutte; L Fourcade
Journal:  Biol Trace Elem Res       Date:  1990-05       Impact factor: 3.738

4.  Changes in collagen and elastin in rabbit right-ventricular pressure overload.

Authors:  R B Low; W S Stirewalt; P Hultgren; E S Low; B Starcher
Journal:  Biochem J       Date:  1989-11-01       Impact factor: 3.857

5.  Disruption of the myocardial extracellular matrix leads to cardiac dysfunction.

Authors:  H E Kim; S S Dalal; E Young; M J Legato; M L Weisfeldt; J D'Armiento
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

Review 6.  Therapeutic potential of copper chelation with triethylenetetramine in managing diabetes mellitus and Alzheimer's disease.

Authors:  Garth J S Cooper
Journal:  Drugs       Date:  2011-07-09       Impact factor: 9.546

Review 7.  Myocardial diseases of animals.

Authors:  J F Van Vleet; V J Ferrans
Journal:  Am J Pathol       Date:  1986-07       Impact factor: 4.307

8.  Alteration of collagenous protein profile in congestive heart failure secondary to myocardial infarction.

Authors:  V Pelouch; I M Dixon; R Sethi; N S Dhalla
Journal:  Mol Cell Biochem       Date:  1993-12-22       Impact factor: 3.396

Review 9.  Role of extracellular matrix proteins in heart function.

Authors:  V Pelouch; I M Dixon; L Golfman; R E Beamish; N S Dhalla
Journal:  Mol Cell Biochem       Date:  1993-12-22       Impact factor: 3.396

Review 10.  Extracellular matrix-mediated cellular communication in the heart.

Authors:  Iñigo Valiente-Alandi; Allison E Schafer; Burns C Blaxall
Journal:  J Mol Cell Cardiol       Date:  2016-01-14       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.